TD-AF879054

ELISA

Rabbit

IgG

Polyclonal

Certolizumab

Certolizumab

The product is specific for Certolizumab. This antibody serves as an excellent positive control for Certolizumab immunogenicity (ADA) assays.

Please contact with the lab for this information.

Purified by antigen affinity column.

CAS: 428863-50-7

Liquid

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

ELISA　|　IHC　|　WB

1:5000-1:20000　|　1:50-1:500　|　1:500-1:2000

The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles.

Certolizumab is a Fab fragment of a monoclonal antibody to human tumor necrosis factor alpha (TNFα) which has potent antiinflammatory activity and is used in the therapy of severe rheumatoid arthritis and inflammatory bowel disease. Antibodysystem Anti-Certolizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Certolizumab.• Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial., PMID:37423647• Certolizumab Pegol: A Review in Moderate to Severe Plaque Psoriasis., PMID:32207094• Certolizumab Pegol in Plaque Psoriasis: Considerations for Pregnancy., PMID:33769772• Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient., PMID:37905433• Certolizumab pegol for hidradenitis suppurativa: Case report and literature review., PMID:33135826• Certolizumab pegol for induction of remission in Crohn's disease., PMID:31476018• ACG Clinical Guideline: Management of Crohn's Disease in Adults., PMID:29610508• [Certolizumab]., PMID:31208736• Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation., PMID:27140438• Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis., PMID:31917928

Western blot analysis was performed using anti-Certolizumab polyclonal antibody at 1ug/mL on recombinant Certolizumab (Catalog No.:TD-HF879016).

For research use only.